JEROME H. REICHMAN is the Bunyan S. Womble Professor of Law at Duke University School of Law, Durham, North Carolina. He has written and lectured widely on diverse aspects of intellectual property law, including comparative and international intellectual property and the connection between intellectual property and international trade laws. His articles in this last area particularly address problems that developing countries face in implementing the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement). He is aconsultant to numerous intergovernmental and nongovernmental organizations, a member of the Board of Editors for the Journal of International Economic Law, and of the Scientific Advisory Board of Il Diritto di Autore (Rome).
He is a graduate of the University of Chicago, where he was a Hutchins Scholar and an early entrant. He is also a graduate of Yale Law School. He worked for the UN in Geneva in the 1970s and then taught at Ohio State and Vanderbilt. He has taught at Duke for the last 17 years.
He recently published two books: Governing Digitally Integrated Genetic Resources, Data and Literature: Global Intellectual Property Strategies for a Redesigned Microbian Research Commons, co-authored with Tom Dedeurwaerdere and Paul Uhlir, (Cambridge University Press, 2016) and The World Blind Union Guide to the Marrakesh Treaty, co-authored with Lawrence Helfer, Molly Land and Ruth Okediji, (Oxford University Press, 2017)
In collaboration with Keith Maskus, he published International Public Goods and Transfer of Technology Under a Globalized Intellectual Property Regime (Cambridge Press, 2005). His most recent publication in this area is Why the Nagoya Protocol to the CBD matters to Science and Industry in Canada and the United States (Center for International Governance Innovation [CIGI], Ontario, Canada, 2018)
Other relevant publications include Intellectual Property in the 21st Century: Will Developing Countries Lead or Follow? (2009); Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options (2009); Rethinking the Role of Clinical Trial Data in International Intellectual Property Law: The Case for a Public Goods Approach (2009); Harmonization Without Consensus: Critical Reflections on Drafting a Substantive Patent Law Treaty (2007) (co-authored with Prof. Rochelle Dreyfuss); and The Doha Round’s Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines Under the Amended TRIPS Provisions (2007) (co-authored with Prof. Fred Abbott).